1. Joshi N, Miller DQ. Doxycycline revisited. Arch Intern Med 1997; 157 (13): 1421–8.
2. Навашин С.М., Навашин П.С. Тетрациклины в лечении бактериальных инфекций. Антибиотики и химиотерапия. 1993; 38 (1): 53–62.
3. Данные сайта: www.cdc.gov/STD/Chlamydia2011/state.htm
4. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59 (RR-12): 1–110.
5. Lanjouw E, Ossewaarde JM, Stary A et al. 2010 European guideline for the management of Chlamydia trachomatis infection. J STD AIDS 2010; 21 (11): 729–37.
6. Ковалев Ю.Н., Ильин Н.И. Болезнь Рейтера. Челябинск, 1993.
7. Сидельникова С.М., Агабабова Э.Р., Стысин Е.А. и др. Клиническая симптоматика и некоторые вопросы терапии болезни Рейтера. Терапевт. арх. 1978; 6: 99–103.
8. Хамраев А.А. Влияние антибиотиков на клиническую симптоматику и показатели хламидийной инфекции против урогенной болезни Рейтера. Автореф. дис. … канд. мед. наук. М., 1990.
9. Lauhio A, Leirisalo-Repo M, Lähdevirta J et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991; 34 (1): 6–14.
10. Wollenhaupt J, Hammer M, Pott HG, Zeidler H. A double-blind placebo-controlled comparison of 2 weeks versus 4 months treatment with doxycycline in Chlamydia-induced arthritis. Arthritis Rheum1997; 40: 143.
11. Sieper J, Braun J. Treatment of reactive arthritis with antibiotics. Br J Rheumatol 1998; 37 (7): 717–20.
12. Carter JD, Gérard HC, Whittum-Hudson JA, Hudson AP. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight? Int J Clin Rheumtol 2011; 6 (3): 333–45.
13. Ананьева Л.П. Болезнь Лайма – мультидисциплинарная проблема. Избранные лекции по клинической ревматологии. Под ред В.А.Насоновой, Н.В.Бунчука. М.: Медицина, 2001; с. 148–58.
14. Барскова В.Г. Ревматические синдромы при различных исходах болезни Лайма. Автореф. дис. ... канд. мед. наук. М., 1995.
15. Wormser GP, Dattwyler RJ, Shapiro ED et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006; 43 (9): 1089–134.
16. Лайковская Е.Э. Изучение эффективности антибактериальной терапии ранней стадии лайм-боррелиоза (болезни Лайма) при длительном проспективном наблюдении. Автореф. дис. ... канд. мед. наук. М., 1997.
17. Москвитина Г.Г. Экстренная профилактика иксодовых клещевых боррелиозов на основе индикации возбудителя в присосавшихся клещах. Автореф. дис. … канд. биол. наук. М., 1996.
18. Puéchal X. Whipple’s disease. Ann Rheum Dis. [Epub: 2013 Jan 3.]
19. Van La M, Barbry P, Raoult D, Renesto P.Molecular basis of Tropheryma whipplei doxycycline susceptibility examined by transcriptional profiling. J Antimicrob Chemother 2007; 59 (3): 370–7.
20. Nordström D, Lindy O, Lauhio A et al. Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int 1998; 17 (5): 175–80.
21. Sreekanth VR, Handa R, Wali JP et al. Doxycycline in the treatment of rheumatoid arthritis – a pilot study. J Assoc Physicians India 2000; 48 (8): 804–7.
22. Singh JA, Furst DE, Bharat A et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012; 64 (5): 625–39.
23. Smith K, Leyden JJ. Safety of doxycycline and minocycline: a systematic review. Clin Ther 2005; 27 (9): 1329–42.
24. Steingrímsson O, Olafsson JH, Thorarinsson H et al. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother 1990; 25 (Suppl. A): 109–14.
25. Martin DH, Mroczkowski TF, Dalu ZA et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992; 327 (13): 921–5.
26. Nilsen A, Halsos A, Johansen A et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males. Genitourin Med 1992; 68 (5): 325–7.
27. Lauharanta J, Saarinen K, Mustonen MT, Happonen HP. Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males. J Antimicrob Chemother 1993; 31 (Suppl. E): 177–83.
28. Lister PJ, Balechandran T, Ridgway GL, Robinson AJ. Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men. J Antimicrob Chemother 1993; 31 (Suppl. E): 185–92.
29. Hammerschlag MR, Golden NH, Oh MK et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. J Pediatr 1993; 122 (6): 961–5.
30. Steingrímsson O, Olafsson JH, Thórarinsson H et al. Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994; 21 (1): 43–6.
31. Stamm WE, Hicks CB, Martin DH et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA 1995; 274 (7): 545–9.
32. Thorpe EM Jr, Stamm WE, Hook EW 3rd et al. Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises. Genitourin Med 1996; 72 (2): 93–7.
33. Hillis SD, Coles FB, Litchfield B et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. Sex Transm Dis 1998; 25 (1): 5–11.
34. Tan HH, Chan RK. An open label comparative study of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in males and Chlamydia trachomatis cervicitis in female sex workers in an STD clinic in Singapore. Singapore Med J 1999; 40 (8): 519–23.

Б.С.Белов

ФГБУ Научно-исследовательский институт ревматологии им. В.А.Насоновой РАМН, Москва